Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
Authors
Keywords
Anamorelin HCl, Ghrelin receptor agonist, Cancer anorexia-cachexia syndrome, Body weight, Growth hormone
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume 5, Issue 4, Pages 329-337
Publisher
Wiley
Online
2014-09-29
DOI
10.1007/s13539-014-0159-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults
- (2013) Ralf Nass et al. ANNALS OF INTERNAL MEDICINE
- Cancer Cachexia Pathophysiology and Translational Aspect of Herbal Medicine
- (2013) H. Suzuki et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
- (2013) R. Northrup et al. SUPPORTIVE CARE IN CANCER
- Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients
- (2012) Yuichiro Hiura et al. CANCER
- The potential of ghrelin in the treatment of cancer cachexia
- (2012) Josep M Argilés et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study
- (2012) José M. Garcia et al. SUPPORTIVE CARE IN CANCER
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- The role of C-terminal part of ghrelin in pharmacokinetic profile and biological activity in rats
- (2011) Naomi Morozumi et al. PEPTIDES
- Cancer Cachexia: Mechanisms and Clinical Implications
- (2011) Claire L. Donohoe et al. Gastroenterology Research and Practice
- Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
- (2010) Shontelle Dodson et al. Annual Review of Medicine
- Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients
- (2010) Kent Lundholm et al. CANCER
- Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment
- (2010) Nagi B. Kumar et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
- (2009) Niels Møller et al. ENDOCRINE REVIEWS
- Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers
- (2009) José M. Garcia et al. GROWTH HORMONE & IGF RESEARCH
- Effects of an Oral Growth Hormone Secretagogue in Older Adults
- (2009) Heidi K. White et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)
- (2009) Yixuan Gong et al. PLoS One
- Regulation of muscle mass by growth hormone and IGF-I
- (2008) C P Velloso BRITISH JOURNAL OF PHARMACOLOGY
- Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice
- (2008) Simona Perboni et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation